Safety and Efficacy of Dalbavancin Versus Vancomycin in the Treatment of Catheter-Related Bloodstream Infections

NCT00057369 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

88

Enrollment

INDUSTRY

Sponsor class

Conditions

Bacteremia

Interventions

DRUG: dalbavancin

Sponsor

Vicuron Pharmaceuticals